Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)
China
· Delayed Price · Currency is CNY 7.75
+0.09 (1.17%)
Mar 10, 2026, 3:00 PM CST
SHA:603567 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,195 | 10,897 | 11,423 | 11,988 | 14,412 | 9,477 | Upgrade
|
| Market Cap Growth | -31.50% | -4.61% | -4.71% | -16.82% | 52.08% | -12.40% | Upgrade
|
| Enterprise Value | 10,279 | 13,767 | 13,636 | 13,478 | 17,271 | 11,076 | Upgrade
|
| Last Close Price | 7.66 | 11.46 | 11.80 | 12.35 | 14.68 | 10.71 | Upgrade
|
| PE Ratio | - | 24.87 | 24.16 | 64.65 | 43.40 | 21.72 | Upgrade
|
| Forward PE | - | 36.69 | 36.69 | 36.69 | 36.69 | 36.69 | Upgrade
|
| PS Ratio | 4.51 | 4.03 | 3.64 | 2.85 | 3.49 | 2.78 | Upgrade
|
| PB Ratio | 0.99 | 1.31 | 1.42 | 1.69 | 2.04 | 1.72 | Upgrade
|
| P/TBV Ratio | 1.15 | 1.60 | 1.69 | 1.90 | 2.12 | 1.80 | Upgrade
|
| P/FCF Ratio | 19.30 | - | - | - | - | - | Upgrade
|
| P/OCF Ratio | 12.86 | 66.32 | - | - | - | 61.07 | Upgrade
|
| EV/Sales Ratio | 6.44 | 5.09 | 4.35 | 3.20 | 4.18 | 3.25 | Upgrade
|
| EV/EBITDA Ratio | - | 18.19 | 37.43 | - | 42.55 | 14.94 | Upgrade
|
| EV/EBIT Ratio | - | 22.83 | 73.50 | - | 63.88 | 18.92 | Upgrade
|
| EV/FCF Ratio | 27.58 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.45 | 0.40 | 0.39 | 0.41 | 0.42 | 0.58 | Upgrade
|
| Debt / EBITDA Ratio | - | 4.32 | 8.38 | - | 7.23 | 4.33 | Upgrade
|
| Debt / FCF Ratio | 8.84 | - | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.42 | 0.27 | 0.21 | 0.26 | 0.20 | 0.30 | Upgrade
|
| Net Debt / EBITDA Ratio | -86.99 | 2.94 | 4.62 | -31.21 | 3.40 | 2.25 | Upgrade
|
| Net Debt / FCF Ratio | 8.28 | -89.56 | -2.93 | -2.55 | -1.56 | -2.34 | Upgrade
|
| Asset Turnover | 0.13 | 0.22 | 0.26 | 0.36 | 0.38 | 0.35 | Upgrade
|
| Inventory Turnover | 0.70 | 1.21 | 2.14 | 4.07 | 3.34 | 1.80 | Upgrade
|
| Quick Ratio | 1.22 | 2.11 | 2.16 | 1.27 | 2.04 | 1.92 | Upgrade
|
| Current Ratio | 1.76 | 2.85 | 2.60 | 1.65 | 2.37 | 2.66 | Upgrade
|
| Return on Equity (ROE) | -4.32% | 5.34% | 6.17% | 2.70% | 5.30% | 8.14% | Upgrade
|
| Return on Assets (ROA) | -0.87% | 2.99% | 0.96% | -1.17% | 1.55% | 3.80% | Upgrade
|
| Return on Invested Capital (ROIC) | -1.61% | 4.97% | 1.94% | -1.59% | 2.54% | 7.59% | Upgrade
|
| Return on Capital Employed (ROCE) | -2.10% | 5.90% | 1.90% | -2.80% | 3.10% | 7.30% | Upgrade
|
| Earnings Yield | -4.62% | 4.02% | 4.14% | 1.55% | 2.30% | 4.60% | Upgrade
|
| FCF Yield | 5.18% | -0.23% | -5.02% | -6.10% | -6.12% | -7.53% | Upgrade
|
| Dividend Yield | 1.96% | 1.31% | 1.70% | 0.23% | 0.72% | - | Upgrade
|
| Payout Ratio | - | 74.00% | 33.48% | 131.34% | 43.28% | 76.15% | Upgrade
|
| Buyback Yield / Dilution | 0.12% | 0.01% | 0.14% | -8.87% | -1.82% | 0.01% | Upgrade
|
| Total Shareholder Return | 2.07% | 1.31% | 1.83% | -8.64% | -1.10% | 0.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.